Renal replacement therapy in Europe - A summary of the 2010 ERA-EDTA Registry Annual Report

Anneke Kramer*, Vianda S. Stel, José Maria Abad Diez, Ramón Alonso De La Torre, Encarnacin Bouzas Caamaño, Svjetlana Cala, Higini Cao Baduell, Pablo Castro De La Nuez, Harijs Cernevskis, Frederic Collart, Cécile Couchoud, Johan De Meester, Ljubica Djukanovic, Manuel Ferrer-Alamar, Patrik Finne, Damian Fogarty, María De Los Angeles García Bazaga, Liliana Garneata, Eliezer Golan, Raquel Gonzalez FernándezJames G. Heaf, Andries Hoitsma, George A. Ioannidis, Mykola Kolesnyk, Reinhard Kramar, Torbjrn Leivestad, Aurelio Limido, Frantisek Lopot, Fernando MacArio, Angela Magaz, Eduardo Martín-Escobar, Wendy Metcalfe, Marlies Noordzij, Mai Ots-Rosenberg, Runolfur Palsson, Celestino Piñera, Maurizio Postorino, Karl G. Prutz, Marina Ratkovic, Halima Resic, Aurelio Rodríguez Hernández, Boleslaw Rutkowski, Kamil Serdengeçti, Tomas Sierra Yebenes, Viera Spustová, Olivera Stojceva-Taneva, Natalia A. Tomilina, Moniek W.M. Van De Luijtgaarden, Karlijn J. Van Stralen, Christoph Wanner, Kitty J. Jager

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


BackgroundThis study provides a summary of the 2010 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at report includes data on renal replacement therapy (RRT) using data from the national and regional renal registries in 29 countries in Europe and bordering the Mediterranean Sea. Individual patient data were received from 27 registries, whereas 18 registries contributed data in aggregated form. We present incidence and prevalence of RRT, transplant rates, survival probabilities and expected remaining lifetimes. The latter two are solely based on individual patient records.ResultsIn 2010, the overall incidence rate of RRT for end-stage renal disease (ESRD) among all registries reporting to the ERA-EDTA Registry was 123 per million population (pmp) (n = 91 798). The highest incidence rate was reported by Turkey (252pmp) and the lowest reported by Montenegro (21 pmp). The overall prevalence of RRT for ESRD at 31 December 2010 among all registries reporting to the ERA-EDTA Registry was 741 pmp (n = 551 005). The prevalence varied from 124 pmp in Ukraine to 1580 pmp in Portugal. The overall number of renal transplantations performed in 2010 among all registries was 29.2 pmp (n = 21 740). The highest overall transplant rate was reported from Spain, Cantabria (73 pmp), whereas the highest transplant rate for living donor kidneys was reported from the Netherlands (28 pmp). For patients who started RRT between 2001 and 2005, the unadjusted 5-year patient survival on RRT was 46.2% [95% confidence interval (CI) 46.0-46.3], and on dialysis 38.6% (95% CI 38.5-38.8). The unadjusted 5-year patient survival after the first renal transplantation performed between 2001 and 2005 was 86.6% (95% CI 86.1-87.1) for deceased donor kidneys and 94.1% (95% CI 93.4-94.8) for living donor kidneys.

Original languageEnglish
Pages (from-to)105-115
Number of pages11
JournalCKJ: Clinical Kidney Journal
Issue number1
StatePublished - Feb 2013
Externally publishedYes


Dive into the research topics of 'Renal replacement therapy in Europe - A summary of the 2010 ERA-EDTA Registry Annual Report'. Together they form a unique fingerprint.

Cite this